Permanent His bundle pacing in heart failure patients: A systematic review and meta-analysis
Zhiyong Qian1, Fengwei Zou2, Yao Wang1
1Department of Cardiology, First Affiliated Hospital, Nanjing Medical University, Nanjing.
Insights
His bundle pacing (HBP) shows promise for heart failure patients unresponsive to cardiac resynchronization therapy (CRT). This alternative pacing method improved left ventricular function and clinical outcomes in observational studies.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) is standard for heart failure with left ventricular (LV) dyssynchrony.
- Approximately 30% of patients do not respond to CRT.
- His bundle pacing (HBP) is emerging as a potential alternative for CRT-eligible patients.
Purpose of the Study:
- To evaluate the efficacy of His bundle pacing (HBP) in patients with heart failure.
- To assess HBP as an alternative to CRT for improving cardiac function and outcomes.
Main Methods:
- Systematic review of PubMed and Embase databases.
- Inclusion of 11 studies with 494 patients.
- Extraction of data on implantation success, QRS duration, pacing thresholds, LV function, and mortality.
Main Results:
- Successful implantation rate of 82.4% for HBP.
- Significant improvement in LV function and clinical outcomes post-HBP (P < 0.001).
- Mean follow-up of 23.7 months showed 5.9% heart failure hospitalization and 9.1% mortality.
Conclusions:
- Permanent HBP demonstrates promising results in heart failure patients.
- Further randomized controlled trials are necessary to confirm HBP efficacy.
Background:
Cardiac resynchronization therapy (CRT) is the standard-of-care therapy for the patients with heart failure and left ventricular (LV) dyssynchrony. However, approximately 30% of the patients show no response. Recent studies have shown that His bundle pacing (HBP) could be an alternative for the patients with CRT indications. The purpose of this study was to evaluate the efficacy of HBP in patients with heart failure.
Methods:
We searched PubMed and Embase databases for studies evaluating HBP in patients with heart failure and LV dyssynchrony. The successful rate of implantation, QRS duration, pacing threshold, LV function at baseline and follow-up, and mortality rates were extracted and summarized.
Results:
Eleven studies including 494 patients were included in this analysis. The overall successful rate for implantation was 82.4%. The main indications for HBP were CRT candidates and cardiomyopathy with atrial fibrillation undergoing atrioventricular node ablation. Permanent HBP resulted in narrow QRS duration of 116.3 ± 13.9 ms after implantation. LV functions, including echocardiographic parameters and clinical outcomes, significantly improved at follow-up (P < 0.001). However, there was a trend of increased capture and bundle branch block correction thresholds at follow-up compared to baseline (P = 0.01 and 0.02, respectively). During a mean follow-up of 23.7 months, 5.9% of the patients experienced heart failure-related hospitalization and the mortality rate was 9.1%.
Conclusion:
Permanent HBP has shown promising results for heart failure patients in small observational studies. Randomized controlled trials are needed to assess the efficacy of HBP in these patients.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management


